December 18, 2024

How ECOG-ACRIN and Caris Life Sciences are teaming up to fight cancer

December 13, 2024

Tamoxifen cuts 15-year recurrence in DCIS without radiation therapy

December 12, 2024

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

December 11, 2024

Does acalabrutinib fit into frontline therapy for patients with mantle cell lymphoma? (Study EA4181)

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

The November 2024 News from ECOG-ACRIN blog is now available

November 25, 2024

Press Release: Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

ECOG-ACRIN Cancer Research Group